-
Rotigotine Hydrochloride in PD Research
2026-09-13
Rotigotine hydrochloride is a versatile dopamine D2/D3 receptor agonist for connecting cellular neuroprotection, dopaminergic signaling research, and rodent Parkinson’s disease models. This workflow-centered guide shows how to select concentrations, compare administration routes, interpret bladder-function data, and troubleshoot reproducibility limits.
-
DNP-Induced seRNA Drives NPC Metastasis
2026-09-12
The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, that promotes nasopharyngeal carcinoma metastasis through an NPM1/c-Myc/NDRG1 regulatory axis. By combining RNA-seq, GRO-seq, ChIP-seq, functional perturbation, animal models, and patient tissue analysis, the work connects chemical exposure to enhancer-mediated transcriptional control and metastatic behavior.
-
Cyanin Chloride in a Human Psoriasis Model
2026-09-12
A 2024 study evaluated cyanin chloride across chemical antioxidant assays, macrophage inflammation, and cytokine-stimulated HaCaT keratinocytes. Its main contribution was to connect reduced inflammatory signaling, STAT3 modulation, transepithelial electrical resistance, and filaggrin expression in one in vitro psoriasis-relevant workflow, while leaving clinical translation and aglycone–glycoside equivalence unresolved.
-
Mitomycin C Workflows for Cancer Research
2026-09-11
Build more interpretable DNA-damage and apoptosis assays with Mitomycin C, from solvent handling through TRAIL-sensitization studies. This practical guide also shows how target-specific controls from antiviral genome-editing research can strengthen cancer assay design without overstating cross-domain evidence.
-
Perphenazine: D2 Antagonist Research Guide
2026-09-11
Perphenazine is a dopamine D2 receptor antagonist with additional histamine, muscarinic, and adrenergic receptor activity. Research benchmarks include mitochondria-mediated cell death induction in SH-SY5Y cells, opioid tolerance suppression in rats, and phenothiazine-associated macrophage ROS and autophagy responses.
-
Biotin-tyramide: TSA Mechanism & Workflow
2026-09-10
Biotin-tyramide is a biotinylation reagent for enzyme-mediated tyramide signal amplification in immunohistochemistry and in situ hybridization. Its HRP-dependent local deposition supports fluorescent or chromogenic streptavidin detection, while product-specific solvent and storage limits define reliable handling.
-
Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells
2026-09-10
The reference study establishes a phenotypic screening strategy for identifying small molecules that reduce SPP1 expression in tumor-associated macrophages and packages selected hits in a TAM-avid CANDI nanoconstruct. Its lead compound, CANDI460, lowered SPP1 in cellular and mouse studies and was associated with tumor remission across multiple murine models, supporting SPP1-high myeloid cells as a therapeutically actionable compartment.
-
BHA Workflows for Oxidative Stress Research
2026-09-09
Build reproducible BHA experiments for reactive oxygen species (ROS) detection, biomolecule protection, and redox-sensitive phenotype testing. This guide combines practical formulation controls with a stereochemistry-inspired assay framework drawn from peptide research.
-
S63845 MCL1 Inhibitor: Apoptosis Workflows
2026-09-09
S63845 provides a selective way to test MCL1 dependence, BAX/BAK-driven mitochondrial apoptosis, and cytochrome c release in cancer models. This practical guide connects dose design and troubleshooting with the emerging role of LACTB-mediated inner-mitochondrial-membrane remodeling.
-
5-Azacytidine Workflows for Leukemia Research
2026-09-08
Build stronger epigenetic experiments with 5-Azacytidine by pairing DNA methylation measurements with viability, apoptosis, and differentiation endpoints. This practical workflow also shows how to use 5-AzaC as a DNMT-focused comparator when evaluating emerging leukemia compounds with additional tubulin activity.
-
RIPA Lysis Buffer for Stroke Protein Workflows
2026-09-08
Build reproducible ischemic-brain protein workflows with strong detergent lysis and a customizable inhibitor strategy. This guide translates fecal microbiota transplantation findings into practical Western blot, immunoprecipitation, ELISA, and kinase-assay preparation decisions.
-
Dutasteride Workflow for Prostate Research
2026-09-07
Build cleaner androgen-mechanism experiments with Dutasteride, a dual 5-alpha-reductase inhibitor that connects direct DHT suppression to proliferation and apoptosis readouts. This practical guide covers stock preparation, dose-response design, assay selection, cross-study interpretation, and troubleshooting for prostate cancer and BPH models.
-
BMX-IN-1 Workflows for Kinase Research
2026-09-05
BMX-IN-1 is an irreversible BMX kinase inhibitor for connecting covalent target inhibition with cancer-cell phenotypes and host-pathogen biology. This practical guide covers dose-response design, lysosomal-acidification assays, apoptosis and cell-cycle readouts, plus troubleshooting for macrophage and tumor-cell workflows.
-
Rotigotine in Experimental Depression Models
2026-09-05
The reference study was among the first systematic evaluations of Rotigotine across several established rodent models of anxiety and depression-like behavior. Its dose- and model-dependent findings suggest antidepressant-like activity at lower exposures, while also showing why locomotor stimulation must be separated from genuine changes in affective behavior.
-
Deracoxib: COX-2 Mechanism and Research Uses
2026-09-04
Deracoxib is a selective COX-2 inhibitor used in canine pain, inflammation, and tumor-cell research. Product-reported concentration ranges support assay planning, but in vitro potency, plasma exposure, and clinical dosing should not be treated as interchangeable measures.